Company: BSTZ
Filing Date: 2025-03-07
Form Type: N-CSR
Source: 0001193125-25-049659
Chunk: 168

Company: BlackRock Science & Technology Term Trust
Filing Date: 2025-03-07
Form: N-CSR
Chunk 168
---
 to waive its investment advisory fees by the amount of investment advisory fees BDJ pays to the Manager indirectly through its investment in money market funds managed by the Manager or its affiliates, through June 30, 2026. The Fee Waiver Agreement may be terminated at any time, without the payment of any penalty, only by BDJ (upon the vote of a majority of the Trustees who are not “interested persons” (as defined in the Investment Company Act of 1940, as amended (the “Investment Company Act”), of BDJ (the “Independent Trustees”)) or a majority of the outstanding voting securities of BDJ), upon 90 days’ written notice by BDJ to the Manager. The following example illustrates BDJ ’ s expenses (including the sales load of $10.00 and offering costs of $0.14) that shareholders would pay on a $1,000 investment in common shares, assuming (i) total net annual expenses of 0.88% of net assets attributable to common shares and (ii) a 5% annual return:

|                         | 1 Year | 3 Years | 5 Years | 10 Years |
| Total expenses incurred |    $19 |     $38 |     $58 |     $117 |

The example should not be considered a representation of future expenses. The example assumes that the estimated “Other expenses” set forth in the Estimated Annual Expenses table are accurate and that all dividends and distributions are reinvested at NAV. Actual expenses may be greater or less than those assumed. BDJ’s actual rate of return may be greater or less than the hypothetical 5% return shown in the example.

Shareholder Update 203

Shareholder Update (unaudited) (continued)

BlackRock Health Sciences Trust (BME) The following table and example are intended to assist shareholders in understanding the various costs and expenses directly or indirectly associated with investing in BME ’ s common shares.

|                                                                             |                                                  BME |
| Shareholder Transaction Expenses                                            |                                                      |
| Maximum sales load (as a percentage of offering price)(a)                   |                                                1.00% |
| Offering expenses borne by the Trust (as a percentage of offering price)(a) |                                                0.02% |
| Dividend reinvestment plan fees                                             | $0.02pershareforopenmarketpurchasesofcommonshares(b) |
| Estimated Annual Expenses(as a percentage of net assets                     
 attributable to common shares)                                              |                                                      |
| Investment advisory fees(c)(d